$Costing template and report : rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia : implementing NICE guidance$
Cover image not available

Costing template and report : rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia : implementing NICE guidance

National Institute for Health and Clinical Excellence

Publication Data

Title Costing template and report : rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia : implementing NICE guidance
Alternative Title Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2010
Publication location London
Language English

Descriptive Notes

"Technology appraisal implementation tools."

Topics

Chronic lymphocytic leukemia :: Chemotherapy :: Great Britain :: Cost effectiveness
Rituximab

Catalogue Data

OBNB ID GBB586471
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99419061

ISBD

P1053 1 online resource (various pagings)
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Costing template and report : rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia : implementing NICE guidance by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.